glp 1 mechanism of action of GLP-1 [25] GLP-1 Receptor Agonists as Treatments

doi: 10.1016/j.diabet.2023.101433 [DOI] [PubMed] [Google Scholar] 53

Among ADMs, semaglutide continues to be the most prescribed medication (1.29% of all prescriptions), although prescription rates decreased (-0.42%)

doi: 10.1155/2014/538737.538737 [DOI] [PMC free article] [PubMed] [Google Scholar] 26.Vittone F., Liberman A., Vasic D., et al

A clinical trial in 2015 linked an undisclosed GLP-1 to significant improvements in OSA severity, while a 2016 clinical trial found that weight loss resulting from liraglutide was significantly associated with a reduction in the apnea-hypopnea index (AHI)

Orforglipron is different because its the first daily pill , giving patients a needle-free option

But researchers are increasingly seeing signs that some benefits may be weight-independent